Dermal absorption of benzene in occupational settings: Estimating flux and applications for risk assessment

Critical Reviews in Toxicology

Volumn 41, Issue 2, 2011, Pages 111-142

  Williams, Pamela R D ^a   Sahmel, Jennifer ^b   Knutsen, Jeffrey ^c   Spencer, John ^d   Bunge, Annette L ^c  

^a E Risk Sciences   (United States)

^b CARDNO CHEMRISK   (United States)

^c Department of Geology and Geological Engineering   (United States)

^d Environmental Profiles Inc   (United States)

Author keywords

Benzene; dermal absorption; dermal flux; OSHA PEL; risk assessment

Indexed keywords

BENZENE; ORGANIC SOLVENT;

AQUEOUS SOLUTION; HUMAN; HUMIDITY; INHALATION; MATHEMATICAL MODEL; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; SKIN INJURY; SKIN SURFACE; STEADY STATE; VOLATILIZATION;

ANIMALIA;

EID: 79551650418     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.530224     Document Type: Review

References (107)

1. ACGIH (American Conference of Governmental Industrial Hygienists). (2001). Benzene. Basis for Treshold Limit Value (TLV). Cincinnati, OH: ACGIH.
2. Adami G, Larese F, Barbieri P, Lo Coco F, Reisenhofer E. (2006). Penetration of benzene, toluene, and xylenes contained in gasolines through human abdominal skin in vitro. Toxicology In Vitro 20:1321-1330.
3. Alikhan A, Farahmand S, Maibach HI. (2009). Correlating percutaneous absorption with physicochemical parameters in vivo in man: Agricultural, steroid, and other organic compounds. J Appl Toxicol 29: 590-596.
4. Barry BW, Harrison SM, Dugard PH. (1985a). Correlation of thermodynamic activity and vapour difusion through human skin for the model compound, benzyl alcohol. J Pharmacy Pharmacol 37: 84-90.
5. Barry BW, Harrison SM, Dugard PH. (1985b). Vapour and liquid difusion of model penetrants through human skin; correlation with thermodynamic activity. J Pharmacy Pharmacol 37:226-235.
6. Bird RB, Stewart WE, Lightfoot EN. (2007). Transport Phenomena. Rev. 2nd ed.; NewYork: J. Wiley & Sons: New York.
7. Blank IH and, McAulife BS. (1985). Penetration of benzene through human skin. J Invest Dermatol 85:522-526.
8. Blank IH and, Scheuplein RJ (1969). Transport into and within the skin. Brit J Dermatol 81, 4-10.
9. Bowman A and, Maibach HI (2000). Infuence of evaporation and solvent mixtures on the absorption of toluene and n-butanol in human skin in vitro. Ann Occup Hyg 44, 125-135.
10. Brandau R, Lippold BH . (1982). Dermal and Transdermal Absorption. Stuttgart: Wissenschaftliche Verlag Gesellschaft, 257 p., Stuggart, 1982.
11. Brenner D, Kalnas J, Teitelbaum DT. (1998). Skin absorption of benzene as a contaminant in other solvents. Eur J Oncol 3:399-405.
12. Brenner D, Kalnas J, Teitelbaum DT. (1999). Chronic myelogenous leukaemia due to skin absorption of benzene as a contaminant in other solvents: A report of two cases. Eur. J. Oncol 4:603-605.
13. Bronough RL, Stewart RF, Congdon ER, Giles AL. (1982). Methods for in vitro percutaneous absorption studies I. Comparison with in vivo results. Toxicol Appl Pharmacol 62:474-480.
14. Bronaugh RL and, Maibach HI. (1983). In vitro percutaneous absorption. In: Marzulli FN, Maibach HI, eds. Dermatotoxicology, 2nd ed. by Marzulli FN and Maibach HI. New York: Hemisphere Publishing, pp.117-129.
15. Bronaugh RL and, Stewart R F (1985). Methods for in vitro percutaneous absorption studies. V. Permeation through damaged skin. J Pharm Sci. 74, 1062-1066.
16. Bronaugh RL, Stewart RF, Wester RC, Bucks D, Maibach HI, Anderson J. (1985). Comparison of percutaneous absorption of fragrances by humans and monkeys. Food Chem Toxicol. 23:111-114.
17. Bronaugh RL, Stewart RF, Simon M. (1986a). Method for in vitro percutaneous absorption studies. VII: Use of excised human skin. J Pharm. Sci. 75:1094-1097.
18. Bronaugh RL, Weingarten DP, Lowe NJ. (1986b). Diferential Rates of percutaneous absorption through the eczematous and normal skin of a monkey. J Invest Dermatol. 87:451-453.
19. Brouwer, D.H, Semple, S, Marquart, J,Cherrie, JW. (2001). A dermal model for spray painters. Part I: Subjective exposure modeling of spray paint deposition. Ann Occup Hyg 45:15-23.
20. Bucks D, Guy RH, Maibach HI. (1991). Efects of occlusion. In: Bronough RL, Maibach HI, eds. In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications. Boca Raton, FL: CRC Press: pp., 85-114.
21. Bunge AL and, Cleek RL. (1995). A new method for estimating dermal absorption from chemical exposure: 2. Efect of molecular weight and octanol-water partitioning. Pharmaceutical Res 12:88-95.
22. Chilcott RP, Barai N, Beezer AE, Brain SI, Brown MB, Bunge AL, Burgess SE, Cross S, Dalton CH, Dias M, Farinha A, Finnin BC, Gallagher SJ, Green DM, Gunt H, Gwyther RL, Heard CM, Jarvis CA, Kamiyama F, Kasting GB, Ley EE, Lim ST, McNaughton GS, Morris A, Nazemi MH, Pellett MA, DuPlessis J, Quan YS, Raghavan SL, Roberts M, Romonchuk W, Roper CS, Schenk D, Simpson A, Traversa BD, Trottet L, Watkinson A, Wilkinson SC, Williams FM, Yamamoto A, and Hadgraft J. (2005). Inter- and intralaboratory variation of in vitro difusion cell measurements: An international multicenter study using quasi-standardized methods and materials. J Pharmaceutical Sci 94:632-638.
23. Chowhan ZT and, Pritchard R. (1978). Efect of surfactants on percutaneous absorption of naproxen I: Comparisons of rabbit, rat, and human excised skin. J Pharmaceut Sci. 67:1272-1274.
24. Cleek RL and, Bunge AL. (1993). A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharmaceutical Res 10:497-506.
25. COSHH Essentials. (2010). Error! Hyperlink reference not valid. Accessed on: July 19, 2010.
26. EC (European Commission). (2004). Guidance Document on Dermal Absorption Brussels, Belgium: Health and Consumer Protection Directorate-General, Directorate E: Food Safety: Plant Health, Animal Health and Welfare, International Questions. Sanco/222/2000 rev. 7. 19 March 2004.
27. ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals). (1993). Percutaneous absorption. Monograph No. 20. ECETOC, Brussels, Belgium.: ECETOC.
28. Feldmann RJ and, Maibach HI. (1967). Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol. 48: 181-183.
29. Fiserova-Bergerova V. (1993). Relevance of occupational skin exposure. Ann Occup Hyg 37:673-685.
30. Fiserova-Bergerova V, Pierce JT, Droz PO. (1990). Dermal absorption potential of industrial chemicals: Criteria for skin notation. Am J Ind Med 17:617-635.
31. Fiserova-Bergerova V. (1993). Relevance of occupational skin exposure. Ann Occ Hyg 37:673-685.
32. Franz TJ. (1975). Percutaneous absorption. On the relevance of in vitro data. J Investigative Dermatology 64:190-196.
33. Franz TJ. (1978). Te fnite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Curr Probl Dermatol 7:58-68.
34. Franz TJ. (1982). Percutaneous absorption of benzene. In: MacFarland HN, ed. Proceedings of the Symposium: Te Toxicology of Petroleum Hydrocarbons. MacFarland HN, ed. Washington, DC: American Petroleum Institute, May 1982. pp. 108-114.
35. Franz TJ. (1984). Percutaneous absorption of benzene. Chapter 5 In: McFalrand HN, ed. Advances in Modern Environmental Toxicology. Vol. 6. McFalrand, HN (ed). Scientifc Publishers: Princeton, NJ.: Scientifc Publishers, pp. 61-70.
36. Franz TJ, Lehman PA, Raney SG. (2009). Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol 22:276-286.
37. Frasch FH and, Barbero AM (2008). Te transient dermal exposure: Teory and experimental examples using skin and silicone membranes. J Pharm Sci 97, 1578-1592.
38. Frasch FH and, Barbero AM (2009). A paired comparison between human skin and hairless guinea pig skin in vitro permeability and lag time measurements for 6 industrial chemicals. Cutaneous and Ocular Toxicol 28 (3) 107-113.
39. Frasch FH, Zang LY, Barbero AM, Anderson SE. (2010). In vitro dermal penetration of 4-chloro-3-methylphenol from commercial metal working fuid and aqueous vehicles. J Toxicol Environ Health, Part A 73 (20):1394-1405.
40. Gilbert TE. (1971). Rate of evaporation of liquids into air. J Paint Technol 43 (562):93-97.
41. Hanke J, Dutkiewicz T, Piotrowski J. (1961). Te absorption of benzene through human skin. Reprinted in English in 2000 asin: Int J Occup Environ Health 6:104-111.
42. Hawkins GS and, Reifenrath WG. (1986). Infuence of skin source, penetration cell fuid, and partition coefcient on in vitro skin penetration. J Pharmaceut Sci 75:378-381.
43. Hui X, Wester RC, Barbadillo S, Cashmore A, Maibach HI. (2009). In vitro percutaneous absorption of benzene in human skin. Cutan Ocular Toxicol 28:65-70.
44. IPCS (International Programme on Chemical Safety). (2004). Harmonization Document No. 1. IPCS Risk Assessment Terminology. Part 1: IPCS/OECD Key Generic Terms Used in Chemical Hazard/Risk Assessment. Part 2: IPCS Glossary of Key Exposure Assessment Terminology. Geneva, Switzerland: World Health Organization (WHO) Press, 2004.
45. Jacobs RR and, Phanprasit W (1993). An in vitro comparison of the permeation of chemicals in vapor and liquid phase through pig skin. Am Ind Hyg Assoc J 54, 569-575.
46. Jakasa I and, Kezic S (2008). Evaluation of in vivo animal and in vitro models for prediction of dermal absorption in man. Human Experimental Toxicol 27, 281-288.
47. Jakobson I, Wahlberg JE, Holmberg B, Johansson G. (1982). Uptake via the blood and elimination of 10 organic solvents following epicutaneous exposure of anesthetized guinea pigs. Toxicol. Appl. Pharmacol. 63:181-187.
48. Kurihara-Bergstrom, T. G. L., Flynn GL, Higuchi WI. (1986). Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: Kinetic and thermodynamic determinants of dimethyl sulfoxide mediated mass transfer of alkanols. J Pharmaceutical Sci 75:479-486.
49. Laitinen J, Kangas J, Pekari K, Liesivuori J. (1994). Short time exposure to benzene and gasoline at garages. Chemosphere 28:197-205.
50. Leung H.W., D.J. Paustenbach DJ. (1994). Techniques for estimating the percutaneous absorption of chemicals due to occupational and environmental exposure. Appl. Occup. Environ. Hyg, 9:187-197.
51. Loden M. (1985). Te in vitro hydrolysis of diisopropyl fuorophosphate during penetration trhough human full-thickness skin and isolated epidermis. J Invest Dermatology 85:335-339.
52. Loden M. (1986a). Te in vitro permeability of human skin to benzene, ethylene glycol, formaldehyde, and n-Hexane. Acta Pharmacol et Toxicol 58:382-389.
53. Loden M. (1986b). Te efect of 4 barrier creams on the absorption of water, benzene, and formaldehyde into excised human skin. Contact Dermatitis 14:292-296.
54. Maibach HI and, Anjo DM (1981). Percutaneous penetration of benzene and benzene contained in solvents used in the rubber industry. Arch Environ Health 36, 256-260.
55. Maibach HI, Feldmann RJ, Milby TH, Serat WF. (1971). Regional variation in percutaneous penetration in man. Arch Environ Health 23:208-211.
56. Marquart, J, Brouwer DH, Gijsbers JHJ, Links IHM, Warren N, van Hemmen JJ. (2003). Determinants of dermal exposure relevant for exposure modeling in regulatory risk assessment. Ann Occup Hyg 47:599-607. (Pubitemid 37432606)
57. Marzulli FN. (1962). Barriers to skin penetration. J Invest Dermatol 39:397-393.
58. Marzulli FN, Brown DWC, Maibach HI. (1969). Techniques for studying skin penetration. Toxicol Appl Pharmacol, Supplement 3:76-83.
59. Marzulli FN. (1962). Barriers to skin penetration. J Invest Dermatol. 39:397-393.
60. McDougal JN and, Boeniger MF (2002). Methods for assessing risks of dermal exposures in the workplace. Crit Rev Toxicology 32, 291-327.
61. McDougal JN, Jepson GW, Clewell HJ, Gargas ML, Andersen ME. (1990). Dermal absorption of organic chemical vapors in the rats and humans. Fundam Appl Toxicol 14:299-308.
62. Modjtahedi BS and, Maibach HI. (2008). In vivo percutaneous absorption of benzene in man: Forearm and palm. Food Chemical Toxicol 46:1171-1174.
63. Morgan DL, Copper SW, Carlock DL, Sykora JJ, Sutton B, Mattie DR, McDougal JN. (1991). Dermal absorption of neat and aqueous volatile organic chemicals in the Fischer 344 rat. Environ Res 55:51-63.
64. Monash University. (2001). Lympho-haematopoietic Cancer and Exposure to Benzene in the Australian Petroleum Industry: Technical Report and Appendices. Monash University and Deakin University, June 2001.
65. Nakai JS, Chu I, Li-Muller A, Aucoin R. (1997). Efect of environmental conditions on the penetration of benzene through human skin. J Toxicol Environ Health 51:447-462.
66. Nies E and, Korinth G. (2008). Commentary on "Penetration of benzene, toluene and xylenes contained in gasolines through human abdominal skin in vitro". Toxicology In Vitro 21:275-277.
67. NIOSH (National Institute for Occupational Safety and Health). (2003). NIOSH Manual of Analytic Methods. http://www.cdc.gov/niosh/nmam. Accessed on: July 19, 2010.
68. NIOSH (National Institute for Occupational Safety and Health) (2009). Current Intelligence Bulletin 61: A Strategy for Assigning New NIOSH Skin Notations. Cincinnati, OH: National Institute for Occupational Safety and Health. DHHS (NIOSH) Publication No. 2009-147.
69. July 2009. OECD (Organisation for Economic Cooperation and Development). (2004a). OECD guideline for the testing of chemicals: Skin absorption: In vivo method. No. 427. Paris, France: Organisation for Economic Cooperation and Development. Adopted 13 April 2004.
70. OECD (Organisation for Economic Cooperation and Development). (2004b). OECD guideline for the testing of chemicals: Skin absorption: In vitro method. No. 428. Paris, France: Organisation for Economic Cooperation and Development. Adopted 13 April 2004.
71. Oppl R. F., Kalberlah F. P. G., Evans PG, and J. J. Van Hemmen JJ. (2003). A toolkit for dermal risk assessment and management: An overview. Ann Occ Hyg 47:629-640.
72. OSHA (Occupational Safety and Health Administration). (1987). 29 CFR Part 1910: Occupational Exposure to Benzene; Final Rule Federal Register. Vol. 52, No. 176. Sept 11, 1987. pp. 34460-34578.
73. OSHA (Occupational Safety and Health Administration) (1989). Medical surveillance guidelines for benzene. Occupational Safety and Health Standards, Toxic and Hazardous Substances. http://www.osha.gov/pls/oshaweb/owadisp.show- document?p- table=STANDARDS&p-id = 10045. Accessed on: July 19, 2010.
74. OSHA (Occupational Safety and Health Administration). (2002). Benzene sampling and analytical methods. http://www.osha.gov/dts/sltc/methods/validated/ 1005/1005.html. Accessed on: July 19, 2010.
75. Riviere J. (2005). Chemical Mixtures. Chapter 14 in Dermal Absorption Models in Toxicology and Pharmacology. JE Riviere (ed), Boca Raton, FL:: Taylor & Francis Group, p. 283-304.
76. Ross JH, Dong MH, Krieger RI. (2000). Conservatism in pesticide exposure assessment. Reg Toxicol Pharmacol 31:53-58.
77. Sahmel J, Boeniger M, Knutsen J, ten Berge W, Fehrenbacher M.C. (2009). Dermal exposure modeling. Chapter 13, pp. 105-132
78. Keil C, Simmons C, Anthony R, eds. Mathematical Models for Estimating Occupational Exposure to Chemicals, 2nd ed. Keil C, Simmons, C and Anthony, R., eds. Fairfax, VA: American Industrial Hygiene Association Press, 105-132.
79. Scheuplein RJ. (1965). Mechanisms of percutaneous adsorption. I. Routes of penetration and the infuence of solubility. J Invest Dermatol 45:334-345.
80. Schneider, T, Vermeulen R, Brouwer DH, Cherrie JW, Kromhout H, Fogh CL. (1999). Conceptual model for assessment of dermal exposure. Occup. Environ. Med. 56:765-773.
81. Schneider T., et al. (2000). Dermal exposure assessment. Ann Occup Hyg 44:493-499.
82. Sheehan P, Bogen KT, Hicks J, Goswami E, Brorby G, Lau EC, and Ott B. (2010). Benzene inhalation by parts washers: New estimates based on measures of occupational exposure to solvent coaromatics. Risk Analy 30:1249-1267.
83. Stempfer BN and, Bunge AL (2004). How much chemical in the skin will evaporate? Presentation Presented at Perspectives in Percutaneous Penetration (PPP) Conference, 13-17 April, 2004.
84. La Grande Motte, France. Susten AS, Dames BL, Burg JR, Niemeier RW. (1985). Percutaneous penetration of benzene in hairless mice: An estimate of dermal absorption during tire-building operations. Am J Ind Med 7:323-335.
85. Susten AS, Dames BL, Niemeier RW. (1986). In vivo percutaneous absorption studies of volatile solvents in hairless mice. I. Description of a skin-depot. J Appl Toxicol 6:43-46.
86. Susten AS, Niemeier RW, Simon SD. (1990). In vivo percutaneous absorption studies of volatile solvents in hairless mice. II. Toluene, ethyl benzene, and aniline. J Appl Toxicol 10: 217-225.
87. Trall KD, Poet TS, Corley RA, Tanofo H, Edwards JA, Weitz KK, Hui X, Maibach HI, Wester RC. (2000). A real-time in vivo method for studying the percutaneous absorption of volatile chemicals. Int J Occup Environ Health 6:96-103.
88. Trefel P, Muret P, Muret-D'Aniello P, Coumes-Marquet S, Agache P. (1992). Efect of occlusion on in vitro percutaneous absorption of two compounds with diferent physicochemical properties. Skin Pharmacol 5:108-113.
89. Tsuruta H. (1982). Percutaneous absorption of organic solvents. III. On the penetration rates of hydrophobic solvents through the excised rat skin. Ind Health 20: 335-345.
90. Tsuruta H. (1996). Skin absorption of solvent mixtures: Efect of vehicles on skin absorption of toluene. Ind Health 34:369-378.
91. US EPA (US Environmental Protection Agency). (1992). Dermal Exposure Assessment: Principles and Applications. Interim Report. Washington, DC: Ofce of Health and Environmental Assessment, Exposure Assessment Group. EPA/600/8-91/011B. January 1992.
92. US EPA (US Environmental Protection Agency). (1997). Exposure Factors Handbook. Washington, DC: Ofce of Research and Development, National Center for Environmental Assessment. EPA/600/P-95/002Fa. August 1997.
93. US EPA (US Environmental Protection Agency). (2004). Risk Assessment Guidance for Superfund (RAGS). Volume I: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment). Washington, DC: Ofce of Superfund Remediation and Technology Innovation. EPA/540/R/99/005. July 2004.
94. US EPA (US Environmental Protection Agency). (2007). Dermal Exposure Assessment: A Summary of EPA Approaches. Washington, DC: National Center for Environmental Assessment, Ofce of Research and Development. EPA/600/R-07/040F. September 2007.
95. US EPA US Environmental Protection Agency). (2010). Chemical Screening Tool for Exposures and Environmental Releases. Washington, DC: Ofce of Pollution Prevention and Toxics. http://www.epa.gov/opptintr/exposure/pubs/chemsteer.htm Accessed on: July 19, 2010.
96. van Wendel de Joode B, Brouwer DH, Vermeulen R, van Hemmen JJ, Heederick D, Kromhout H. (2003). DREAM: A method for semi-quantitative dermal exposure assessment. Ann Occup Hyg 47:71-87.
97. Vecchia BE and, Bunge AL. (2005). Animal models: A comparison of permeability coefcients for excised skin from humans and animals. In: Riviere JE, ed.Chapter 15 in Dermal Absorption Models in Toxicology and Pharmacology. J.E. Riviere (ed), Boca Raton, FL: Taylor & Francis Group: Boca Raton, p., 303-365.
98. Wahlberg JE. (1976). Percutaneous toxicity of solvents: A comparative investigation in the guinea pig with benzene, toluene, and 1,1, 2-trichloroethane. Ann Occup Hyg 19:115-119.
99. Walker JD, Whittaker C, and McDougal JN. (1996). Role of the TSCA Interagency Testing Committee in meeting the U.S. Government′s data needs: Designating chemicals for percutaneous absorption testing,. In: Marzulli FN, Maibach HI, eds. Dermatotoxicology, FN Marzulli,and HI Maibach, Eds, 5th ed. Washington, DC: Hemisphere Publishing Corporation, pp. 371-381.
100. Warren ND, Marquart H, Christopher Y, Laitinen J, and Van Hemmen JJ. (2006). Task-based dermal exposure models for regulatory risk assessment. Ann Occup Hyg 50:491-503.
101. Wester RC, Maibach HI. (2000). Benzene percutaneous absorption: Dermal exposure relative to other benzene sources. Int J Occup Environ Health 6:122-126.
102. Wester RC and, Noonan PK (1980). Relevance of animal models for percutaneous absorption. Int J Pharmaceutics 7, 99-110.
103. Wester RC and Maibach HI. (2000). Benzene percutaneous absorption: Dermal exposure relative to other benzene sources. Int J Occup Environ Health 6:122-126.
104. Williams FM. (2006). In vitro studies - -How good are they at replacing in vivo studies for measurement of skin absorption? Environ Toxicol Pharmacol 21:199-203.
105. Williams PRD and, Paustenbach DJ. (2003). Reconstruction of benzene exposure for the plioflm cohort (1936-1976) using Monte Carlo techniques. J Toxicol Environ Health Part A 66, 677-781.
106. WHO (World Health Organization). (2006). Environmental Health Criteria 235: Dermal Absorption. Geneva: WHO Press.
107. Zendzian RP and, Dellarco M. (2003). Validating in vitro dermal absorption studies: An introductory case study. Chapter 18 In: Salem H, Katz SA, eds. Alternative Toxicological Methods. Harry Salem and Sidney A. Katz (eds). CRC Press, Boca Raton, FL.: CRC Press, 207-220.